This content is machine translated Non-small cell lung cancer Focus on current therapy management of NSCLC Non-small cell lung cancer is a common cancer with generally poor prognosis. Scientific advances have led to new forms of therapy increasing the chance of survival. In particular, the development…
View Post 11 min This content is machine translated From chemotherapy to immunotherapy Current system therapy in metastatic non-small cell lung cancer. Detailed molecular diagnosis is now mandatory for non-small cell lung cancer (NSCLC). In the presence of a driver mutation, the corresponding tyrosine kinase inhibitor should be used in the first…
View Post 7 min This content is machine translated Surgical therapy for lung cancer Staging, operability, and prognostic factors determine the indication The choice of therapeutic modalities for lung cancer depends on several factors. Accurate staging, assessment of operability, and knowledge of prognostic factors such as the number of affected lymph node…
View Post 7 min This content is machine translated Metastatic non-small cell lung cancer Drug therapy 2014 Determination of EGFR mutational status and EML-ALK translocations in patients with metastatic adenocarcinoma has therapeutic implications and should be requested at diagnosis. Maintenance treatment with pemetrexed in patients with non-squamous…
View Post 2 min This content is machine translated Bronchus carcinoma Dawn in non-small cell lung cancer? At the beginning of every medical advance is the intention and hope of the researcher to understand a problem in order to then bring it to a solution. Hope is…
